Literature DB >> 2848892

Leukotriene C4 production from human eosinophils in vitro. Role of eosinophil chemotactic factors on eosinophil activation.

N Tamura1, D K Agrawal, R G Townley.   

Abstract

We studied the role of naturally occurring eosinophil chemotactic factors on leukotriene (LT)C4 production from highly purified (87.1 +/- 2.4%) normodense eosinophils. Platelet activating factor (PAF) directly induced LTC4 production from eosinophils in a dose (10(-9) to 10(-5) M) and a time-dependent manner. PAF (10(-5) M) induced 0.74 +/- 0.08 ng of LTC4 production/10(6) eosinophils. However, lyso-PAF, eosinophil chemotactic factor of anaphylaxis, and LTB4 failed to induce LTC4 production within the tested range. Furthermore, the pre-incubation of eosinophils with 5 micrograms/ml of cytochalasin B did not alter the chemotactic factor-induced LTC4 production. When eosinophils were stimulated by the submaximal concentration (1 microgram/ml) of calcium ionophore A23187, the pre-incubation of eosinophils with 10(-6) M or 10(-5) M of PAF, or 10(-5) M of eosinophil chemotactic factor of anaphylaxis significantly enhanced LTC4 production up to 163.9 +/- 17.5% (p less than 0.05), 279.2 +/- 32.9% (p less than 0.01) and 165.2 +/- 21.2% (p less than 0.05) of the control, respectively. However, the pre-incubation with lyso-PAF or LTB4 failed to enhance A23187-induced LTC4 production. The pre-incubation of eosinophils with phosphatidyl serine also failed to enhance A23187-induced LTC4 production. However, the direct stimulation of protein kinase C by PMA enhanced the submaximal concentration of A23187-induced LTC4 production from eosinophils up to 179.5 +/- 20.9% (p less than 0.05) of the control. Our findings indicate that PAF and ECF-A work not only as chemotactic factors but also induce a functionally active state of eosinophils probably through their post-receptor mechanisms, and contribute to the inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2848892

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  The effect of WEB 2086 on PAF-induced eosinophil chemotaxis and LTC4 production from eosinophils.

Authors:  H Miyagawa; M Nabe; R J Hopp; C Okada; A K Bewtra; G Townley
Journal:  Agents Actions       Date:  1992-09

2.  Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.

Authors:  W F Owen; J Petersen; K F Austen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 3.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

4.  A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.

Authors:  D K Agrawal; M Takami; S Ono
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

5.  Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects.

Authors:  H Tenor; A Hatzelmann; M K Church; C Schudt; J K Shute
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 1. Effect on passive anaphylactic bronchoconstriction in guinea pigs.

Authors:  M Uchida; N Imanishi; T Sugasawa; S Morooka
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 7.  Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis.

Authors:  M Peters-Golden; M M Gleason; A Togias
Journal:  Clin Exp Allergy       Date:  2006-06       Impact factor: 5.018

8.  Leukotriene C(4) biosynthesis in isolated August rat peritoneal leukocytes.

Authors:  J M Huebner; R R Eversole; W F Jackson; C D Mackenzie; S R Stapleton; L J Beuving
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.